batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Syndax hit by menin delay 29 July 2024 Argenx steps back from subcutaneous Vyvgart 26 July 2024 Novartis buys into Dren’s bispecifics 25 July 2024 Ipsen endorses Day One, but US launch remains key 25 July 2024 Hookipa hopes for a head and neck fast track 24 July 2024 Cellectar clarity fails to win over investors 24 July 2024 Astra bets on an EGFR future beyond Tagrisso 24 July 2024 Merck’s subQ Keytruda headscratcher 23 July 2024 Load More